Giuseppe D. Di Stasio
Salerno, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Tailored Molecular Imaging of Pheochromocytoma and Paraganglioma: Which Tracer and When.
Journal: Neuroendocrinology
Published: July 02, 2021
The Role of Molecular Imaging in a Muscle-Invasive Bladder Cancer Patient: A Narrative Review in the Era of Multimodality Treatment.
Journal: Diagnostics (Basel, Switzerland)
Published: March 22, 2021
Prognostic value of PET parameters in patients with pleomorphic lung cancer: Results from a single institution.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 12, 2021
PET/CT in thyroid cancer - the importance of BRAF mutations.
Journal: Nuclear medicine review. Central & Eastern Europe
Published: November 20, 2019
The Molecular Effects of Ionizing Radiations on Brain Cells: Radiation Necrosis vs. Tumor Recurrence.
Journal: Diagnostics (Basel, Switzerland)
Published: July 08, 2019
99mTc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases).
Journal: Current radiopharmaceuticals
Published: January 23, 2019
Nuclear Medicine in Prostate Cancer: A New Era for Radiotracers.
Journal: World journal of nuclear medicine
Published: May 03, 2018
Microvascular Invasion in HCC: The Molecular Imaging Perspective.
Journal: Contrast media & molecular imaging
Published: May 02, 2018
Gamma Emitters in Pancreatic Endocrine Tumors Imaging in the PET Era: Is there a Clinical Space for 99mTc-peptides?
Journal: Current radiopharmaceuticals
Published: April 28, 2018
Is there a clinical usefulness for radiolabeled somatostatin analogues beyond the consolidated role in NETs?
Journal: The Indian journal of radiology & imaging
Published: January 31, 2018
Last Updated: 09/26/2026